{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:10:38Z","timestamp":1794618638972,"version":"4.9.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"crossref","award":["NMRPG3D0421"],"award-info":[{"award-number":["NMRPG3D0421"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"crossref","award":["NSC 103-2314-B-182A-083"],"award-info":[{"award-number":["NSC 103-2314-B-182A-083"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>The impact of immune cells (ICs) expressing various markers remains poorly understood in nonmetastatic colorectal cancer patients who have undergone colectomy. Here, we aimed to clarify the correlation between IC density and clinical parameters and survival.<\/jats:p>\n            <jats:p>Programmed death protein-1 (PD-1), programmed cell death protein ligand-1 (PD-L1), clusters of differentiation (CD)-3, CD-8, and CD45RO immunostaining was performed for 421 patients using tissue microarray and automatic counting. Tumor stroma area immune density was assessed in comparison to clinical histological factors and surgical outcomes.<\/jats:p>\n            <jats:p>High-density CD-8 expression was significantly associated with current smoking habits or a smoking history (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.006). High-density of PD-1 expression was correlated with Lynch syndrome patients (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001) and with patients who did not consume alcohol (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.034). A significant decrease in CR45RO expression density was associated with aging (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.002 and <jats:italic toggle=\"yes\">r<\/jats:italic>\u200a=\u200a\u20130.014), and high-density CD-3, CD-8, and PD-1 expression was significantly associated with right colon tumor location (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). High CD-3 and PD-L1 expression was significantly associated with early tumor T-staging (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.018 and <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.002). High-density PD-1 expression was significantly correlated with mucinous type adenocarcinoma (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.027) and poor differentiation (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). For treatment outcomes, multivariate analysis confirmed that patients exhibiting high-density PD-L1 expression possessed significantly longer disease free survival (adjusted hazard ratio: 0.752, 95% confidence interval [CI]: 0.61\u20130.92, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.006) and overall survival (adjusted hazard ratio: 0.872, 95% CI: 0.75\u20131.91, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.064)<\/jats:p>\n            <jats:p>Significantly varied density in IC subsets was related to distinct demographic or clinic-histological factors. The presence of high-density PD-L1-expressing ICs is an independent favorable prognostic factor for disease free survival and overall survival among stage I to III colorectal cancer patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028573","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T13:05:07Z","timestamp":1642770307000},"page":"e28573","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["A high density of PD-L1-expressing immune cells is significantly correlated with favorable disease free survival in nonmetastatic colorectal cancer"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0814-5645","authenticated-orcid":false,"given":"Ya-Ting","family":"Kuo","sequence":"first","affiliation":[{"name":"Division of Colon and Rectal Surgery, Department of Surgery, Chang Gung Memorial Hospital, Lin-Kou Medical Center, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Kai","family":"Liao","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Department of Surgery, Chang Gung Memorial Hospital, Lin-Kou Medical Center, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tse-ching","family":"Chen","sequence":"additional","affiliation":[{"name":"Chang Gung University, College of Medicine, Taoyuan, Taiwan"},{"name":"Department of Pathology, Chang Gung Memorial Hospital, Lin-Kou Medical Center, Taoyuan, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Chou","family":"Lai","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Department of Surgery, Chang Gung Memorial Hospital, Lin-Kou Medical Center, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sum-Fu","family":"Chiang","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Department of Surgery, Chang Gung Memorial Hospital, Lin-Kou Medical Center, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jy-Ming","family":"Chiang","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Department of Surgery, Chang Gung Memorial Hospital, Lin-Kou Medical Center, Taoyuan, Taiwan"},{"name":"Chang Gung University, College of Medicine, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"R1-20250618","first-page":"4165","article-title":"The prognostic significance of the tumor-infiltrating programmed cell death-1+ to CD8+ lymphocyte ratio in patients with colorectal cancer","volume":"37","author":"Shibutani","year":"2017","journal-title":"Anticancer Res"},{"key":"R2-20250618","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12307-011-0068-5","article-title":"Immune cells in colorectal cancer: prognostic relevance and role of MSI","volume":"4","author":"Deschoolmeester","year":"2011","journal-title":"Cancer Microenviron"},{"key":"R3-20250618","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pag\u00e8s","year":"2018","journal-title":"Lancet"},{"key":"R4-20250618","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00262-003-0388-5","article-title":"Prognostic value of the CD4+\/CD8+ ratio of tumor infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumor cells","volume":"52","author":"Diederichsen","year":"2003","journal-title":"Cancer Immunol Immunother"},{"key":"R5-20250618","doi-asserted-by":"crossref","first-page":"8584","DOI":"10.18632\/oncotarget.24196","article-title":"PD-L1 expression in colorectal cancer defines three subsets of tumor immune microenvironments","volume":"9","author":"Valentini","year":"2018","journal-title":"Oncotarget"},{"key":"R6-20250618","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/j.clcc.2018.09.007","article-title":"Stromal PD-1\/PD-L1 expression predicts outcome in colon cancer patients","volume":"18","author":"Wyss","year":"2019","journal-title":"Clin Colorectal Cancer"},{"key":"R7-20250618","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/medicina55110723","article-title":"Intratumoral cytotoxic T-lymphocyte density and PD-L1 expression are prognostic biomarkers for patients with colorectal cancer","volume":"55","author":"Calik","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"R8-20250618","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12885-020-6553-9","article-title":"Immune classification for the PD-L1 expression and tumor-infiltrating lymphocytes in colorectal adenocarcinoma","volume":"20","author":"Noh","year":"2020","journal-title":"BMC Cancer"},{"key":"R9-20250618","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"R10-20250618","doi-asserted-by":"crossref","first-page":"24269","DOI":"10.18632\/oncotarget.8169","article-title":"PD-L1 is an independent prognostic predictor in gastric cancer of Western patients","volume":"7","author":"B\u00f6ger","year":"2016","journal-title":"Oncotarget"},{"key":"R11-20250618","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/cas.13229","article-title":"Prognostic value of programmed death-ligand 1 expression in patients with stage III colorectal cancer","volume":"108","author":"Koganemaru","year":"2017","journal-title":"Cancer Sci"},{"key":"R12-20250618","article-title":"Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer: relationship with sidedness and prognosis","volume":"7","author":"Berntsson","year":"2018","journal-title":"Oncoimmunology"},{"key":"R13-20250618","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.ejca.2013.02.015","article-title":"Clinical impact of programmed cell death ligand 1 expression in colorectal cancer","volume":"49","author":"Droeser","year":"2013","journal-title":"Eur J Cancer"},{"key":"R14-20250618","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fphar.2019.00139","article-title":"The prognostic and clinicopathological roles of PD-L1 expression in colorectal cancer: a systematic review and meta-analysis","volume":"10","author":"Li","year":"2019","journal-title":"Front Pharmacol"},{"key":"R15-20250618","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/modpathol.2016.139","article-title":"Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma","volume":"29","author":"Lee","year":"2016","journal-title":"Mod Pathol"},{"key":"R16-20250618","first-page":"20608","article-title":"Prognostic value of immunoscore and PD-L1 expression in metastatic colorectal cancer patients with different RAS status after palliative operation","volume":"59","author":"Liu","year":"2018","journal-title":"Biomed Res Int"},{"key":"R17-20250618","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1158\/2326-6066.CIR-15-0302","article-title":"Immune-derived PD-L1 gene expression defines a subgroup of stage II\/III colorectal cancer patients with favorable prognosis who may be harmed by adjuvant chemotherapy","volume":"4","author":"Dunne","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"R18-20250618","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12885-019-5345-6","article-title":"Programmed death ligand-1 expression in stage II colon cancer \u2013 experiences from a nationwide population based cohort","volume":"19","author":"Eriksen","year":"2019","journal-title":"BMC Cancer"},{"key":"R19-20250618","article-title":"PD-L1 as a prognostic factor in early-stage colon carcinoma within the immunohistochemical molecular subtype classification","volume":"13","author":"Pablo","year":"1943","journal-title":"Cancers"},{"key":"R20-20250618","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1158\/1078-0432.CCR-20-2085","article-title":"Spatial and temporal heterogeneity of PD-L1 expression and tumor mutational burden in gastroesophageal adenocarcinoma at baseline diagnosis and after chemotherapy","volume":"26","author":"Zhou","year":"2020","journal-title":"Clin Cancer Res"},{"key":"R21-20250618","doi-asserted-by":"crossref","first-page":"7139","DOI":"10.3390\/ijms21197139","article-title":"Spatial and temporal changes in PD-L1 expression in cancer: the role of genetic drivers, tumor microenvironment and resistance to therapy","volume":"21","author":"Shklovskaya","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R22-20250618","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/SLA.0000000000002803","article-title":"Microsatellite instability and programmed cell death-ligand 1 expression in stage II\/III gastric cancer: post hoc analysis of the CLASSIC randomized controlled study","volume":"270","author":"Choi","year":"2019","journal-title":"Ann Surg"},{"key":"R23-20250618","doi-asserted-by":"crossref","first-page":"225","DOI":"10.31557\/APJCP.2020.21.1.225","article-title":"Immunohistochemical expression of programmed death ligand-1 (PDL-1) in colorectal carcinoma and its correlation with stromal tumor infiltrating lymphocytes","volume":"21","author":"Elfishawy","year":"2020","journal-title":"Asian Pac J Cancer Prev"},{"key":"R24-20250618","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/modpathol.2016.185","article-title":"Clinicopathologic profile, immunophenotype, and genotype of CD274 (PD-L1)-positive colorectal carcinomas","volume":"30","author":"Inaguma","year":"2017","journal-title":"Mod Pathol"},{"key":"R25-20250618","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/ijc.30869","article-title":"Clinical impact of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a cohort study","volume":"141","author":"Berntsson","year":"2017","journal-title":"Int J Cancer"},{"key":"R26-20250618","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/ijerph15051033","article-title":"Tobacco smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: a mechanistic review","volume":"15","author":"Strzelak","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"R27-20250618","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/jnci\/djy137","article-title":"Smoking and risk of colorectal cancer sub-classified by tumor-infiltrating T cells","volume":"111","author":"Hamada","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"R28-20250618","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1080\/07357907.2020.1793349","article-title":"Clinical impact of PD-L1 expression for survival in curatively resected colon cancer","volume":"38","author":"Jung","year":"2020","journal-title":"Cancer Invest"},{"key":"R29-20250618","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.2147\/OTT.S190168","article-title":"Prognostic and clinicopathological value of PD-L1 in colorectal cancer: a systematic review and meta-analysis","volume":"12","author":"Yang","year":"2019","journal-title":"Onco Targets Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T12:01:57Z","timestamp":1750248117000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028573","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"assertion":[{"value":"2021-02-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}